Skip to main navigation Skip to search Skip to main content

Acquired Hemophilia A After Nivolumab Therapy in a Patient With Metastatic Squamous Cell Carcinoma of the Lung Successfully Managed With Rituximab

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e560-e563
JournalClinical Lung Cancer
Volume20
Issue number5
DOIs
StatePublished - Sep 2019

Keywords

  • Acquired hemophilia A
  • Bethesda assay
  • Immunotherapy
  • Nivolumab
  • PD-1

Cite this